Device Trial Radar · NCT05862558
Intravascular Lithotripsy in High Risk Calcified Iliac Anatomy for Transfemoral TAVR
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Mar 30, 2023
Primary completion
Oct 1, 2026
Study completion Oct 1, 2027
Sponsor
- Lead sponsor
- Baylor Research InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Shockwave Medical, Inc.
- First posted
- May 17, 2023
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To assess the efficacy and safety of Intravascular Lithotripsy (IVL) in subjects undergoing transfemoral TAVR in patients with severe iliac disease, prohibitive for transfemoral TAVR in patients with severe symptomatic aortic stenosis, otherwise considered for alternative access TAVR. (e.g. trans-carotid)
Conditions
- Iliac Disease
- Aortic Valve Stenosis
Interventions
Shockwave BalloonDevice
Intravascular lithotripsy (IVL) performed with the Shockwave balloon (Shockwave Medical Inc) enables treatment of calcified stenosis of the peripheral arteries by using sonic pressure waves to selectively disrupt superficial and deep calcium without impacting healthy tissue
Primary outcomes
What the sponsor says the trial is designed to measure.
- Acute technical success per the DISRUPT PAD definition at the time of interventionTime frame: At time of IVL procedure
- Success rate of transfemoral delivery of a TAVR system post IVL within 30 days of treatmentTime frame: At the time of TAVR procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Baylor Scott and White Heart Hospital
Plano, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.